Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Enterprise Value (2021 - 2026)

MDxHealth has reported Enterprise Value over the past 7 years, most recently at -$29.0 million for Q1 2026.

  • For Q1 2026, Enterprise Value rose 37.96% year-over-year to -$29.0 million; the TTM value through Mar 2026 reached -$29.0 million, up 37.96%, while the annual FY2025 figure was -$29.0 million, 37.96% up from the prior year.
  • Enterprise Value was -$29.0 million for Q1 2026 at MDxHealth, roughly flat from -$29.0 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $22.5 million in Q4 2022 and bottomed at -$46.8 million in Q4 2024.
  • The 5-year median for Enterprise Value is -$29.0 million (2025), against an average of -$18.7 million.
  • Year-over-year, Enterprise Value skyrocketed 146.66% in 2022 and then tumbled 379.19% in 2024.
  • Over 5 years, Enterprise Value stood at $22.5 million in 2022, then dropped by 25.51% to $16.8 million in 2023, then tumbled by 379.19% to -$46.8 million in 2024, then skyrocketed by 37.96% to -$29.0 million in 2025, then changed by 0.0% to -$29.0 million in 2026.
  • The last three reported values for Enterprise Value were -$29.0 million (Q1 2026), -$29.0 million (Q4 2025), and -$46.8 million (Q1 2025) per Business Quant data.